The present application discloses a novel class of heterocycles as class I PI3Ks inhibitors. The compounds claimed herein could be used alone or in combination therapies for the treatment of a wide range of disorders such as autoimmune, inflammatory and allergic diseases, asthma, COPD, parasitic infections, diabetes, and cancer.
本申请公开了一类新型的
杂环化合物,作为I类
PI3K
抑制剂。本文所声称的化合物可单独使用,也可与其他疗法结合治疗多种疾病,如自身免疫性、炎症性和过敏性疾病、哮喘、慢性阻塞性肺疾病、寄生虫感染、糖尿病和癌症。